Please see Frontier Channel’s coverage of this event.
- Third “Strategies for Engineered Negligible Senescence” Conference (SENS3)
- Queens’ College, Cambridge, England
- September 6-10, 2007
The purpose of the SENS conference series, like all the SENS initiatives (such as the journal Rejuvenation Research and the Methuselah Mouse Prize), is to expedite the development of truly effective therapies to postpone and treat human aging by tackling it as an engineering problem: not seeking elusive and probably illusory magic bullets, but instead enumerating the accumulating molecular and cellular changes that eventually kill us and identifying ways to repair — reverse — those changes, rather than merely to slow down their further accumulation.